Paper23912396
Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma.
Sharma BK and 9 others. Mol Cell Biochem, 2013. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma. Papers, record 23912396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23912396
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiogenesis Inducing Agents | Major topic |
| Angiogenesis Inhibitors | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Angiostatins | |
| Endostatins | |
| Humans | |
| Kaplan-Meier Estimate | |
| Multivariate Analysis | |
| Neoplasm Staging | |
| Prognosis | |
| Proportional Hazards Models | |
| ROC Curve | |
| Vascular Endothelial Growth Factor A | |
| Vesicular Transport Proteins |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15786555 | Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. | World J Gastroenterol | 2005 | https://conductscience.org/library/papers/15786555 | PubMed |
| 2 | 12734082 | Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery. | Ann Surg Oncol | 2003 | https://conductscience.org/library/papers/12734082 | PubMed |
| 3 | 18465238 | The expression of hypoxia-inducible factor-1alpha in hepatitis B virus-related hepatocellular carcinoma: correlation with patients' prognosis and hepatitis B virus X protein. | Dig Dis Sci | 2008 | https://conductscience.org/library/papers/18465238 | PubMed |
| 4 | 19948069 | Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery. | BMC Cancer | 2009 | https://conductscience.org/library/papers/19948069 | PubMed |
| 5 | 9755235 | Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: correlation with angiostatin generation and its clinical significance. | Hepatology | 1998 | https://conductscience.org/library/papers/9755235 | PubMed |
| 6 | 9245707 | Suppression of tumor growth with recombinant murine angiostatin. | Biochem Biophys Res Commun | 1997 | https://conductscience.org/library/papers/9245707 | PubMed |
| 7 | 10728711 | Local imbalance of proangiogenic and antiangiogenic factors: a potential mechanism of focal necrosis and dormancy in tumors. | Cancer Res | 2000 | https://conductscience.org/library/papers/10728711 | PubMed |
| 8 | 9393749 | Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo. | Cancer Res | 1997 | https://conductscience.org/library/papers/9393749 | PubMed |
| 9 | 22382631 | Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy. | J Gastroenterol | 2012 | https://conductscience.org/library/papers/22382631 | PubMed |
| 10 | 15069550 | High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study. | Oncol Rep | 2004 | https://conductscience.org/library/papers/15069550 | PubMed |
| 11 | 24048796 | V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials. | Cancer | 2011 | https://conductscience.org/library/papers/24048796 | PubMed |
| 12 | 11810769 | [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma]. | Zhonghua Zhong Liu Za Zhi | 2001 | https://conductscience.org/library/papers/11810769 | PubMed |
| 13 | 16410224 | Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling. | Endothelium | 2005 | https://conductscience.org/library/papers/16410224 | PubMed |
| 14 | 15605080 | Increased endostatin/collagen XVIII expression correlates with elevated VEGF level and poor prognosis in hepatocellular carcinoma. | Mod Pathol | 2005 | https://conductscience.org/library/papers/15605080 | PubMed |
| 15 | 10842189 | Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo. | Int J Cancer | 2000 | https://conductscience.org/library/papers/10842189 | PubMed |
| 16 | 11592607 | Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. | J Hepatol | 2001 | https://conductscience.org/library/papers/11592607 | PubMed |
| 17 | 18795712 | Recent evidence in the treatment of small hepatocellular carcinoma. | Hepatogastroenterology | 2008 | https://conductscience.org/library/papers/18795712 | PubMed |
| 18 | 17581268 | Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma. | Am J Gastroenterol | 2007 | https://conductscience.org/library/papers/17581268 | PubMed |
| 19 | 9008168 | Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. | Cell | 1997 | https://conductscience.org/library/papers/9008168 | PubMed |
| 20 | 19197197 | Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study. | J Clin Gastroenterol | 2009 | https://conductscience.org/library/papers/19197197 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939948 | Liver Cirrhosis and Septic Shock Attenuate the Increase in Plasma Endostatin Concentrations That Is Associated with Acute Kidney Injury Requiring Dialysis. | Biomedicines | 2026 | https://conductscience.org/library/papers/42939948 | PubMed |
| 41898378 | Anti-Angiogenic Features of Endostatin in Obesity, Liver Fibrosis, and Hepatocellular Carcinoma. | Biomedicines | 2026 | https://conductscience.org/library/papers/41898378 | PubMed |
| 41513003 | OGT-enriched Hepatocyte-derived Extracellular Vesicles Promote Capillarization of Liver Sinusoidal Endothelial Cells in Metabolic Dysfunction-associated Steatotic Liver Disease. | Cell Mol Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/41513003 | PubMed |
| 33143149 | The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma. | Cells | 2020 | https://conductscience.org/library/papers/33143149 | PubMed |
| 30701027 | Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma. | Oncotarget | 2018 | https://conductscience.org/library/papers/30701027 | PubMed |
| 29876326 | Serum Endostatin Levels in Oral Squamous Cell Carcinoma. | Iran J Otorhinolaryngol | 2018 | https://conductscience.org/library/papers/29876326 | PubMed |
| 25978323 | Repeated-measures implication of hepatocellular carcinoma biomarkers in living donor liver transplantation. | PLoS One | 2015 | https://conductscience.org/library/papers/25978323 | PubMed |
| 25364263 | Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives. | Onco Targets Ther | 2014 | https://conductscience.org/library/papers/25364263 | PubMed |
| 25279166 | Clinical significance of serum and tumor tissue endostatin evaluation in operable non-small cell lung cancer. | Biomed Rep | 2014 | https://conductscience.org/library/papers/25279166 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANGPT2 | 285 | PubTator's text mining | https://conductscience.org/library/genes/285 | NCBI Gene |
| COL18A1 | 80781 | PubTator's text mining | https://conductscience.org/library/genes/80781 | NCBI Gene |
| PLG | 5340 | PubTator's text mining | https://conductscience.org/library/genes/5340 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
| VPS51 | 738 | PubTator's text mining | https://conductscience.org/library/genes/738 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23912396
GET https://conductscience.org/api/papers/v1/23912396/references?page=2